ARHGAP17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.440400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.094000E-01
Normal-vs-Stage2
3.473600E-01
Normal-vs-Stage3
3.088000E-01
Normal-vs-Stage4
3.367400E-01
Stage1-vs-Stage2
3.161000E-01
Stage1-vs-Stage3
9.141000E-01
Stage1-vs-Stage4
6.128400E-01
Stage2-vs-Stage3
3.421800E-01
Stage2-vs-Stage4
7.779800E-01
Stage3-vs-Stage4
6.645400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.437600E-01
Normal-vs-AfricanAmerican
3.414400E-01
Normal-vs-Asian
3.223400E-01
Caucasian-vs-AfricanAmerican
8.924600E-01
Caucasian-vs-Asian
4.730200E-01
AfricanAmerican-vs-Asian
7.449400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.396400E-01
Normal-vs-Female
3.496800E-01
Male-vs-Female
5.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.575800E-01
Normal-vs-Age(41-60Yrs)
3.677400E-01
Normal-vs-Age(61-80Yrs)
3.320800E-01
Normal-vs-Age(81-100Yrs)
3.571600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.649400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.446600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.390200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.407900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.913000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.171800E-01
Normal-vs-Daily Drinker
3.312600E-01
Normal-vs-Weekly Drinker
3.585400E-01
Normal-vs-Occasional Drinker
3.391000E-01
Normal-vs-Social Drinker
3.484000E-01
Non Drinker-vs-Daily Drinker
6.302800E-01
Non Drinker-vs-Weekly Drinker
2.868200E-01
Non Drinker-vs-Occasional Drinker
5.819400E-01
Non Drinker-vs-Social Drinker
3.855000E-01
Daily Drinker-vs-Weekly Drinker
4.616800E-01
Daily Drinker-vs-Occasional Drinker
8.664400E-01
Daily Drinker-vs-Social Drinker
6.156800E-01
Weekly Drinker-vs-Occasional Drinker
6.786600E-01
Weekly Drinker-vs-Social Drinker
8.147800E-01
Occasional Drinker-vs-Social Drinker
8.195000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.312200E-01
Normal-vs-Grade 2
7.674800E-01
Normal-vs-Grade 3
7.685000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.600800E-01
Grade 1-vs-Grade 3
3.837800E-01
Grade 1-vs-Grade 4
6.312200E-01
Grade 2-vs-Grade 3
9.810600E-01
Grade 2-vs-Grade 4
7.674800E-01
Grade 3-vs-Grade 4
7.685000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.438200E-01
Normal-vs-NonDiabetic
3.390600E-01
Diabetic-vs-NonDiabetic
8.365200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.582000E-01
Normal-vs-NoPancreatitis
3.387800E-01
Pancreatitis-vs-NoPancreatitis
3.878600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.495600E-01
Normal-vs-N1
3.455200E-01
N0-vs-N1
8.466000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.652400E-01
Normal-vs-TP53-NonMutant
2.732000E-01
TP53-Mutant-vs-TP53-NonMutant
7.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
